ArticleImmunity, inflammation and disease2021

Rigosertib inhibits MEK1-ERK pathway and alleviates lipopolysaccharide-induced sepsis.

Yin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.